This project will support OneCare Biotechnologies, a Canadian startup developing a blood-based diagnostic test to guide treatment decisions for individuals with psychotic disorders such as schizophrenia. These conditions are often misdiagnosed or inappropriately treated, leading to poorer health outcomes and higher healthcare costs. While OneCare has made strong progress in developing its technology, it now […]
Read More